Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06100900· Phase 1· BioCryst Pharmaceuticals· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error